BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6216932)

  • 1. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions.
    Miller WR; Humeniuk V; Forrest AP
    Breast Cancer Res Treat; 1981; 1(3):267-72. PubMed ID: 6216932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of dehydroepiandrosterone and dehydroepiandrosterone sulphate in blood and tissue. Studies of normal women and women with breast or endometrial cancer.
    Jones DL; James VH
    J Steroid Biochem; 1987 Jan; 26(1):151-9. PubMed ID: 2950279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of dehydroepiandrosterone sulphate by breast cysts: possible role in the development of breast cancer.
    Lai LC
    Cancer Detect Prev; 1995; 19(5):441-5. PubMed ID: 7585731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen conjugates in human breast cyst fluids.
    Miller WR; Roberts MM; Creel RJ; Yap PL; Kelly RW; Forrest AP
    J Natl Cancer Inst; 1982 Nov; 69(5):1055-8. PubMed ID: 6215521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid.
    Lai LC; Ghilchik MW; Shaikh NA; Reed MJ; James VH
    Br J Cancer; 1989 Sep; 60(3):320-3. PubMed ID: 2528985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary cortisol and dehydroepiandrosterone sulphate levels in postmenopausal women with primary breast cancer.
    Read GF; Wilson DW; Campbell FC; Holliday HW; Blamey RW; Griffiths K
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):477-83. PubMed ID: 6222900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of androgen conjugates and oestrone sulphate in patients with breast cysts.
    Scott WN; Hawkins RA; Killen E; Miller WR
    J Steroid Biochem; 1990 Mar; 35(3-4):399-402. PubMed ID: 2139152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between levels of dehydroepiandrosterone-sulphate and prolactin in human breast cyst fluid.
    Angeli A; Boccuzzi G; Agrimonti F; Brignardello E; Barbadoro E; Dogliotti L
    Tumori; 1982 Oct; 68(5):393-6. PubMed ID: 6217610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone sulphate plasma levels in normal women and patients with benign breast disease.
    Parlati E; Liberale I; Morelli P; Serva P; Travaglini A; Piccione A; Menini E; Dell'Acqua S
    J Endocrinol Invest; 1992 Feb; 15(2):99-102. PubMed ID: 1314859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer.
    Helzlsouer KJ; Gordon GB; Alberg AJ; Bush TL; Comstock GW
    Cancer Res; 1992 Jan; 52(1):1-4. PubMed ID: 1530765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.
    Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F
    Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the content and morphology of human breast microcysts.
    Dixon JM; Scott WN; Miller WR
    Eur J Surg Oncol; 1985 Jun; 11(2):151-4. PubMed ID: 3159597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of epidermal growth factor in human breast cyst fluids: correlation with dehydroepiandrosterone-sulphate and electrolyte concentrations.
    Smith K; Miller WR; Fennelly JA; Matthews JN; Scott WN; Harris AL
    Int J Cancer; 1989 Aug; 44(2):229-32. PubMed ID: 2527206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease.
    Boccuzzi G; Brignardello E; Massobrio M; Bonino L
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1099-102. PubMed ID: 2958288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood levels of dehydroepiandrosterone sulfate (DHEA-S) and the risk of breast cancer].
    Gomes P; Cassanas G; Halberg F; Hermida R; Robel P; Baulieu EE; Lakatua D; Haus E
    C R Acad Sci III; 1988; 306(7):261-4. PubMed ID: 2967730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of human breast cysts according to electrolyte and androgen conjugate composition.
    Miller WR; Dixon JM; Scott WN; Forrest AP
    Clin Oncol; 1983 Sep; 9(3):227-32. PubMed ID: 6225590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adrenal androgens in women with primary operable breast cancer and their relationship with age and body mass index.
    Aspinall SR; Cook DB; Shenton BK; Griffiths AB; Griffith CD; Bliss RD; Lennard TW
    Breast; 2003 Feb; 12(1):63-71. PubMed ID: 14659357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between prolactin, dehydroepiandrosterone sulphate and testosterone in normally menstruating females.
    Wathen NC; Perry L; Hodgkinson S; Chard T
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):173-5. PubMed ID: 3160207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone concentration in breast cancer tissue is related to its plasma gradient across the mammary gland.
    Brignardello E; Cassoni P; Migliardi M; Pizzini A; Di Monaco M; Boccuzzi G; Massobrio M
    Breast Cancer Res Treat; 1995; 33(2):171-7. PubMed ID: 7749143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.